ClinicalTrials.Veeva

Menu

Paracervical Block During II-trimester Abortion

K

Kristina Gemzell Danielsson

Status

Completed

Conditions

Second Trimester Medical Abortion

Treatments

Drug: bipuvacain
Other: NaCl

Study type

Interventional

Funder types

Other

Identifiers

NCT01617564
W2010IM

Details and patient eligibility

About

Paracervical blockage can reduce severe pain during second trimester induced medical abortion.

Enrollment

112 patients

Sex

Female

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women who request second trimester medical abortion (13-22 weeks gestation according to ultrasound)
  • 18 years of age or older
  • able to understand and communicate in Swedish
  • able to understand the study related information and willing to give her
  • informed consent to participation in the study

Exclusion criteria

  • Known allergy to bupivakain or related substances

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Triple Blind

112 participants in 2 patient groups

Bupivacain
Active Comparator group
Treatment:
Drug: bipuvacain
Sodium Chloride
Sham Comparator group
Treatment:
Other: NaCl

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems